Delft Imaging Systems BV is specialised in medical solutions to help screen for the lung disease tuberculosis which still kills 1.6 million people every year. Its portfolio of solutions includes a range of X-ray systems, mobile clinics and artificial intelligence software. In 2016, Delft Imaging opened a branch office in Accra, Ghana and in 2018 in Johannesburg, South Africa. To date, Delft Imaging is active in over 40 different countries and has screened more than 6 million people for tuberculosis.
This funding will support Delft Imaging to implement a cloud-based artificial intelligence tool for the detection of COVID-19 cases, CAD4COVID. The CAD4COVID module analyses a standard chest X-ray image and has been developed with the intention to support the triage of potential COVID-19 cases in resource-constrained settings.
Project contacts not available at the time of disclosure.
ACCESS TO INFORMATION
As part of FMO's ex-ante disclosure (disclosure of transactions before contracting), you can send requests or questions for additional information to: email@example.com
ACCOUNTABILITY MECHANISM OF FMO
Communities who believe they will be negatively affected by a project funded by the Dutch Development Bank (FMO) may be able to file a complaint with the Independent Complaints Mechanism, which is the joint independent accountability mechanism of the Dutch Development Bank (FMO) and the German Investment Corporation (KfW). A complaint can be filed in writing, by email, post, or online. The complaint can be filed in English or any other language of the complainant. The Independent Complaints Mechanism is comprised of a three-member Independent Expert Panel and it can provide either problem-solving, compliance review or both, in either order. Additional information about this accountability mechanism, including a guide and template for filing a complaint, can be found at: https://www.fmo.nl/independent-complaints-mechanism